scispace - formally typeset
O

Olivier Elemento

Researcher at Cornell University

Publications -  596
Citations -  38936

Olivier Elemento is an academic researcher from Cornell University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 82, co-authored 471 publications receiving 27739 citations. Previous affiliations of Olivier Elemento include Princeton University & Max Planck Society.

Papers
More filters
Journal ArticleDOI

Identification and Genome-Wide Prediction of DNA Binding Specificities for the ApiAP2 Family of Regulators from the Malaria Parasite

TL;DR: A comprehensively surveyed DNA-binding specificities of all 27 members of the ApiAP2 protein family from Plasmodium falciparum revealing unique binding preferences for the majority of these DNA binding proteins and infer the trans-factors associated with previously reported plasmodial cis-elements.
Journal ArticleDOI

Graph convolutional networks for computational drug development and discovery.

TL;DR: This survey provides a systematic review on the emerging field of graph convolutional networks and their applications in drug discovery and molecular informatics and describes the existing applications through four perspectives: molecular property and activity prediction, interaction prediction, synthesis prediction and de novo drug design.
Journal ArticleDOI

Stem Cell Lineage Infidelity Drives Wound Repair and Cancer

TL;DR: It is found that breakdown of stem cell lineage confinement-granting privileges associated with both fates-is not only hallmark but also functional in cancer development and shows that lineage plasticity is critical in wound repair, where it operates transiently to redirect fates.
Journal ArticleDOI

Clonal evolution of chemotherapy-resistant urothelial carcinoma

TL;DR: This work performed whole-exome sequencing and clonality analysis of 72 urothelial carcinoma samples, including 16 matched sets of primary and advanced tumors prospectively collected before and after chemotherapy, to provide insights into how selective pressure from chemotherapy directs the evolution of uroclinical carcinoma and shapes its clonal architecture.